Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease
Status:
Active, not recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
To determine the safety and feasibility of autologous, culture-expanded adipose-derived (AD)
mesenchymal stromal cells (MSCs) in subjects with painful degenerative disc disease (DDD).